icon-folder.gif   Conference Reports for NATAP  
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 22-26 2022
Back grey_arrow_rt.gif
Clinical features predictive of cirrhosis in a large cohort of patients with chronic hepatitis delta infection - Insights from the D-LIVR trial
  EASL 2022 June 22-26 London
Ohad Etzion 1,2, Maria Buti 3,4, David Yardeni 1,2, Adriana Palom 3, Anat Nevo-Shor 1,2, Daniela Munteanu 1,2, Ingrid Choong 5, Lisa Weissfeld 6, Mar Riveiro Barciela 3,4, Naim Abufreha 1,2, Ana Barreira-Diaz 3,4, Rob Howard 7, Tarik Asselah 8, Pietro Lampertico 9 and on behalf of D-LIVR investigators.
1 Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel, 2 Department of Gastroenterology and Liver Diseases, Soroka University Medical Center, Beer-Sheva, Israel, 3 Hospital Vall Hebron, Liver Unit, Barcelona, Spain, 4 Centro de investigación biomédica en red de enfermedades hepáticas y digestivas, Madrid, Spain, 5 Eiger BioPharmaceuticals, Palo Alto, CA, USA, 6 Statistics Collaborative Inc, Washington DC, USA, 7 Veridical Solutions, Del Mar, CA, USA, 8 Department of Hepatology, AP-HP, Hôpital Beaujon, Clichy, France, 9 Division of Gastroenterology and Hepatology, Milan, Italy.